Life Science Nation Newsletter  | November 23,  2017  |  Issue 241


  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Consulting
Life Science Investor Mandates (Nov. 16  - Nov. 22)
With $600M Fund Exclusively Dedicated to Early-Stage Therapeutics
Invests Broadly in Biotech Companies with Strong Oncology and Immunotherapy Interests
Invests Opportunistically in USA and China Life Science Technologies
Invests Up to $20M in Life Science Companies
Supports Early-Stage Innovations with Grants and Multiple Fund Vehicles
Looks Globally For Pre-Clinical and Early Prototype Technologies
Invests in Biotech Companies in North America and Europe
Seeking Innovative Point-of-Care Diagnostics Companies
Invests $400M Fund in Therapeutics, Devices, and Diagnostics Companies
Seeking Medtech and Digital Health Opportunities in Cardiovascular, Neurology, Oncology Indications
In This Issue
News
Nature BioEntrepreneur Features LSN: Aligning Needs
LSN Services
Click to see investors that are a fit for your product and stage of development

Click here if you are a service provider and want to see a list of funded life science companies that are a fit for you

Click here if you want to receive free, targeted early stage dealflow for your life science investment firm

Free Copy of LSN's Book

LSN Videos
By Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series

As we continue our mission of supporting early stage life science companies and investors in connecting and building relationships, LSN would like to give thanks for our supporters, sponsors, clients, RESI attendees, and everyone who has played a part in our network this year. We wish you all success in your partnering, networking and fundraising, and ultimately in bringing new health innovations to market.

It was wonderful to see so many of you at our first RESI NYC event last week, and we look forward to reconnecting in San Francisco in January. In the meantime, we'd like to offer you 10 piping hot mandates from investors all around the world who are looking for early stage startups to connect with. If one of these investors is a potential fit for you, please get in touch.

While you enjoy the spread on your own tables at home, click the mandates below to see what the LSN Investor Platform is serving up:










10. European VC Seeking Medtech and Digital Health Opportunities in Cardiovascular, Neurology, Oncology Indications


QuickFire Challenge
I n honor of the Grand Opening of JLABS @ NYC, Johnson & Johnson Innovation has launched a QuickFire Challenge to award up to four new game-changing early-stage innovation companies with the use of a bench, workstation and access to the JLABS @ NYC community for one year.

This competition will award the person or team(s) who submits the best idea, technology, or solution in the following areas:
  • Consumer healthcare
  • Health technologies
  • Medical devices
  • Therapeutics